Skip to main content

Table 1 Demographics of the cats enrolled in the ASC clinical trial including cell source and outcome

From: A multicenter experience using adipose-derived mesenchymal stem cell therapy for cats with chronic, non-responsive gingivostomatitis

Cat #

Age (years)

Sex

Weight (kg)

Cell source

Treatment site

Response

SI entry

SI exit

Last SI

Follow-up (months)

1

6

MC

4.3

Autologous

UC Davis

Cure

19.8

0

18

2

5

FS

4.7

Autologous

UC Davis

No/minimal

19

19

 

6

3

5

MC

4.5

Autologous

UC Davis

Substantial

14.75

4

 

6

4

9

FS

3.3

Autologous

UC Davis

Substantial

19

12

 

6

5

7

FS

7

Autologous

UC Davis

Substantial

12.75

2

 

12

6

11

MC

5.7

Autologous

UC Davis

Substantial

23.25

7.5

 

6

7

3

MC

5

Autologous

UC Davis

No/minimal

24.75

15.75

 

6

8

9

MC

4.6

Autologous

UC Davis

Cure

23.5

0.5

 

6

9

4.5

FS

3.6

Allogeneic

UC Davis

Cure

24.5

1

12

10

6

MC

11

Allogeneic

UC Davis

No/minimal

17.12

10

 

6

11

10

FS

5.6

Autologous

UC Davis

Substantial

6.25

3.25

 

18

12

3.5

MC

3.9

Autologous

Cornell

Cure

12.75

2

 

24

13

4

MC

4.4

Autologous

Cornell

Substantial

11.25

11

12.7

13

14

4

FS

6.2

Autologous

Cornell

Substantial

13.25

11.25

 

6

15

10

MC

7.3

Allogeneic

Oregon

Substantial

19

11.75

 

6

16

11

FS

3.2

Allogeneic

UC Davis

Cure

24.5

0.5

 

6

17

4

MC

4.1

Allogeneic

UC Davis

No/minimal

8.37

6.25

 

6

18

4

FS

2.9

Autologous

San Francisco

No/minimal

 

6